← All organizations
Highest phase reached
Phase 4
First clinical trial
Jul 1, 2007Last known activity
Nov 7, 2025
Timeline
1990s
- Mar 28, 1995
Simcere Pharmaceutical Co., Ltd— Founded
Drugs by trial phase (81 distinct, 102 trials)
Phase 4 (12 own, 0 via acquisition)
Phase 3 (21 own, 0 via acquisition)
Phase 2 (18 own, 0 via acquisition)
Phase 1 (30 own, 0 via acquisition)
Indications
Studied for
- Adenocarcinoma
- Adenocarcinoma of Lung
- Arthritis
- Arthritis, Rheumatoid
- Ascites
- Bile Duct Neoplasms
- Brain Neoplasms
- Carcinoma
- Carcinoma, Hepatocellular
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Ovarian Epithelial
- Carcinoma, Squamous Cell
- Cerebral Infarction
- Cholangiocarcinoma
- Colorectal Neoplasms
- Communicable Diseases
- Esophageal Neoplasms
- Essential Hypertension
- Gallbladder Neoplasms
- Herpesviridae Infections
- Hypertension
- Infections
- Influenza, Human
- Ischemia
- Leukemia
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, Lymphoid
- Liver Neoplasms
- Lung Neoplasms
- Lymphoma
- Lymphoma, T-Cell
- Melanoma
- Multiple Myeloma
- Nasopharyngeal Carcinoma
- Neoplasm Metastasis
- Neoplasms
- Neoplasms, Plasma Cell
- Neoplasms, Second Primary
- Neurilemmoma
- Neurofibroma
- Neurofibromatoses
- Neurofibromatosis 1
- Neurofibromatosis 2
- Neuroma, Acoustic
- Osteosarcoma
- Ovarian Neoplasms
- Pleural Effusion
- Pleural Effusion, Malignant
- Small Cell Lung Carcinoma
- Stomach Neoplasms
- Stroke
- Virus Diseases
Recent trials (50)
- NCT07265921Lead sponsorPhase 1Nov 7, 2025
- NCT07175233Lead sponsorPhase 2Oct 27, 2025
- NCT07050459Lead sponsorPhase 1May 20, 2025
- NCT07007988Lead sponsorPhase 1Apr 24, 2025
- NCT06680921Lead sponsorPhase 3Feb 28, 2025
- NCT06686745Lead sponsorPhase 1Nov 30, 2024
- NCT06701149Lead sponsorPhase 1Nov 28, 2024
- NCT06654791Lead sponsorPhase 1Oct 17, 2024
- NCT06477835Lead sponsorPhase 3Oct 15, 2024
- NCT06698965CollaboratorPhase 2Oct 13, 2024
- NCT06536036Lead sponsorPhase 1Jul 23, 2024
- NCT06488755Lead sponsorPhase 3Jul 10, 2024
- NCT06488755OfficialPhase 3Jul 10, 2024
- NCT06375044Lead sponsorPhase 1May 24, 2024
- NCT06370416CollaboratorPhase 2Apr 30, 2024
Details
- Founded
- Nanjing, CN Mar 28, 1995
- Last known activity
- Nov 7, 2025